Literature DB >> 25913891

Immunobullous disease and ulcerative colitis: a case series of six patients.

M C Sotiriou1, C W Foo1, C T Scholes2, J J Zone1.   

Abstract

Cases of immunobullous skin disease associated with ulcerative colitis (UC) have been previously reported in the literature. There is no clear explanation for this association. In this series, we report six cases of immunobullous disease in patients with UC and discuss potential mechanisms of pathogenesis proposed to explain these concomitant diseases. The clinical presentation, immunopathology and treatment of six new cases are described and analysed. We report six patients, two with linear IgA bullous dermatosis (LABD), one with bullous pemphigoid (BP), one with mucous membrane pemphigoid (MMP) and two with IgA pemphigus. The patients' ages ranged from 33 to 66 years at the onset of their skin disease, and all but one case had a documented age of UC onset, confirmed with colonoscopy, prior to the development of skin disease. Direct immunofluorescence results in these patients demonstrated IgA basement membrane zone (BMZ) antibodies in the LABD cases, IgG antibodies at the BMZ in the BP and MMP cases, and IgA cell surface antibodies in the patients with IgA pemphigus. Additionally, indirect immunofluorescence was positive in one of the patients with LABD, the patient with BP and both of the patients with IgA pemphigus. The temporal association of UC and skin disease, in addition to the resolution of skin disease with total colectomy in one case, suggests colonic mucosal antigenic stimulation driving immune activation and leading to immunobullous skin disease.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25913891     DOI: 10.1111/bjd.13872

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis.

Authors:  Hiroki Sonoyama; Yoshiyuki Mishima; Shunji Ishihara; Naoki Oshima; Ichiro Moriyama; Kousaku Kawashima; Yuko Chinuki; Eishin Morita; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2019-09-25

2.  A case of pemphigus vulgaris associated with ulcerative colitis.

Authors:  Joo Wan Seo; Jongha Park; Jin Lee; Mi Young Kim; Hyun Ju Choi; Heui Jeong Jeong; Ji Woon Lee; So Young Jung; Woo Kyeong Kim
Journal:  Intest Res       Date:  2018-01-18

3.  A gut connection in mucous membrane pemphigoid: Insights into the role of the microbiome.

Authors:  Abdelrahman M Elhusseiny; Hoda Fakhari; Faraz Bishehsari; Kai Kang; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-09-18       Impact factor: 5.033

Review 4.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

5.  Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis.

Authors:  Laurel L Wessman; Elizabeth K Blixt; David A Wetter; Rachel Y Miest
Journal:  JAAD Case Rep       Date:  2017-07-19

6.  Bullous Pemphigoid with Lymphocytic Colitis: A Case Report and Short Literature Review.

Authors:  Alexandra Sperl; Johann W Bauer; Damian Meyersburg
Journal:  Dermatol Ther (Heidelb)       Date:  2016-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.